Evolution of the Average Target: AstraZeneca PLC

Evolution of the Target Price: AstraZeneca PLC

Changes in Analyst Recommendations: AstraZeneca PLC

78e8a951783eaf.jbRo9WQPvZb3-TBO422PowD7QzgZKjEtgCtGN9zS1yQ.uNsSgyBt2qOerFc2pSa7x1G-C1MpcHZp7RMyX4yZhxa__hyyHnvO1cWKaQ~45faa5e7e785335dbe657b5c375cab54
Sep. 30 AstraZeneca PLC : Deutsche Bank reaffirms its Neutral rating ZD
Sep. 29 AstraZeneca's $2 Billion Investment in Summit Therapeutics Seen as 'Win-Win,' UBS Says MT
Sep. 29 Stocks Defy the Pressure Zonebourse
Sep. 29 AstraZeneca PLC : Jefferies keeps its Buy rating ZD
Sep. 29 AstraZeneca PLC : RBC reaffirms its Buy rating ZD
Sep. 29 AstraZeneca PLC : JP Morgan maintains a Buy rating ZD
Sep. 29 AstraZeneca PLC : Deutsche Bank is Neutral ZD
Sep. 18 Berenberg and Deutsche say buy Bytes Technology AN
Sep. 16 AstraZeneca PLC : Gets a Buy rating from UBS ZD
Sep. 16 Oddo BHF cuts Safestore to neutral, cuts target AN
Sep. 16 AstraZeneca PLC : Buy rating from Jefferies ZD
Sep. 16 AstraZeneca PLC : JP Morgan keeps its Buy rating ZD
Sep. 16 AlphaValue/Baader Europe Notes GSK's Plans to Address Upcoming Patent Cliff; Price Target Down MT
Sep. 15 Guardant Health Could Benefit From AstraZeneca Trial Failure, UBS Says MT
Sep. 15 Deutsche Bank Upgrades AstraZeneca to Hold, Lifts PT MT
Sep. 15 Berenberg Trims Price Target on AstraZeneca to $203 From $214, Keeps Buy Rating MT
Sep. 15 Berenberg Maintains AstraZeneca at Buy as Pipeline Success Offsets Recent Setbacks; Price Target Down MT
Sep. 15 Berenberg likes GSK; Deutsche Bank lifts Astra AN
Sep. 15 AstraZeneca PLC : Berenberg keeps its Buy rating ZD
Sep. 15 AstraZeneca PLC : Deutsche Bank withdraws its Sell rating ZD
Sep. 14 AstraZeneca PLC : JP Morgan reiterates its Buy rating ZD
Sep. 14 AstraZeneca PLC : Jefferies reiterates its Buy rating ZD
Sep. 10 Berenberg Notes AstraZeneca's 'Stellar' Tozorakimab Late-stage Data; Buy Retained MT
Sep. 10 AstraZeneca PLC : Gets a Sell rating from Deutsche Bank ZD
Sep. 10 AstraZeneca PLC : Berenberg reiterates its Buy rating ZD

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+16.27%
+9.08%
+6.1%
+7.94%
+8.57%
+8.12%
+34.02%
-3%
+9.61%
Average +10.75%
Weighted average by Cap. +11.42%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
157.04USD
Average target price
210.47USD
Spread / Average Target
+34.02%
High Price Target
267.78USD
Spread / Highest target
+70.52%
Low Price Target
157.72USD
Spread / Lowest Target
+0.43%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
A